COVID-19: FUJIFILM secures 2 million people in “Avigan”: Currently 700,000 people’s stockpiling

By flu, Drugs, Pharmaceutical

COVID-19: FUJIFILM secures 2 million people in “Avigan”: Currently 700,000 people’s stockpiling

COVID-19:

FUJIFILM Holdings:

On the seat of the online financial conference on May 22,

Explained the current status of the new coronavirus drug candidate “Avigan”.

It announced that it will complete the “delivery for 2 million people, which is the government’s request for additional stockpiling” by the end of FY2020.

At present, there are about 700,000 stockpiles.

The production has started to increase in April, and the production capacity will be gradually improved in the future.

FUJIFILM:

Director Okada: General Manager of Pharmaceutical Business Division

In clinical trials, we will confirm the efficacy and safety of Avigan tablets against the new corona, and proceed to obtain approval for the therapeutic drug.

Newsweek / Japan version official site

https://www.newsweekjapan.jp/stories/world/2020/05/200-20_1.php

More from tokioX :

  1. COVID-19: FUJIFILM, Phase 3 Avigan clinical trial in the US: ‘Appili Therapeutics’
  2. COVID-19: Fujifilm sells Avigan in China: partner with Carelink
  3. COVID-19: FUJIFILM confirms effectiveness in Avigan clinical trial “: To apply for approval next month
  4. COVID-19: Fujifilm ､Avigan clinical trials: Completed in a month
  5. Taiwan’s government organization decides to stockpile Fujifilm’s anti-influenza drug “Avigan® Tablet”
  6. COVID-19: CMIC starts Avigan clinical trial / manufacturing: Phase III trial CRO / CDMO
  7. COVID-19: Clinical trial of “Avigan” in Egypt: starting April 17, administered to 50 people